• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.26% Nasdaq Up 0.23%

    Capricor Therapeutics, Inc. (CAPR)

    -NasdaqCM
    5.85 Down 0.14(2.34%) 3:57PM EDT
    Add to Portfolio
    Prev Close:5.99
    Open:5.99
    Bid:5.50 x 9400
    Ask:5.90 x 700
    1y Target Est:12.00
    Beta:-5.31
    Next Earnings Date:N/A
    Day's Range:5.85 - 6.26
    52wk Range:3.05 - 10.68
    Volume:18,848
    Avg Vol (3m):30,612
    Market Cap:94.90M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CAPR

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):20.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.58
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback